Adding VEGFR-TKIs to chemotherapy and/or hormonal therapy in advanced breast cancer patients: Results of a meta-analysis.
2014
1052 Background: The addition of vascular endothelial growth factor receptor tyrosine kinase inhibitors (VEGFR-TKIs) to chemotherapy and/or hormonal therapy for advanced breast cancer management re...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI